Arctoris is a technology-driven company transforming drug discovery by combining robotics, artificial intelligence (AI), and data science. Their proprietary Ulysses® platform fully automates wet-lab experimentation, generating rich, reproducible data that powers machine learning models for faster and more efficient therapeutic development. Arctoris partners with biotech and pharmaceutical companies worldwide, offering end-to-end drug discovery services from target validation to lead optimization, aiming to bring novel treatments to patients sooner.
Primary global research and development hub, housing the core of the Ulysses® automated drug discovery platform, advanced data science teams, and corporate operations.
State-of-the-art robotics laboratories featuring the Ulysses® platform, advanced automation systems, secure data infrastructure, and facilities for diverse biological and biochemical assays.
An innovative, fast-paced, and highly interdisciplinary environment fostering collaboration between biologists, chemists, data scientists, engineers, and software developers. Emphasizes precision, data-driven decision-making, and a passion for solving complex scientific challenges.
The central node for Arctoris's technological innovation and experimental execution, enabling unparalleled speed, accuracy, and reproducibility in drug discovery research.
Arctoris supports drug discovery programs for partners worldwide through its remotely accessible, automated Ulysses® platform. While its primary R&D center is in the UK, strategic offices in Cambridge, MA (USA) and Singapore facilitate global collaborations, business development, and engagement with pharmaceutical and biotech organizations across North America, Europe, and Asia-Pacific. The cloud-based nature of their platform enables researchers from any location to design, execute, and analyze complex experiments.
Cherwell Innovation Centre, 77 Heyford Park
Upper Heyford
Oxfordshire
United Kingdom
Address: One Broadway, 14th Floor, Cambridge, MA 02142, USA
To expand Arctoris's footprint and collaborations in the US, a critical market for biopharmaceutical innovation, investment, and R&D.
Address: 3 Biopolis Drive, #05-12 Synapse, Singapore 138623
To establish and grow Arctoris's presence in the APAC market, fostering collaborations and supporting global drug discovery initiatives from a key Asian hub.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Arctoris' leadership includes:
Arctoris has been backed by several prominent investors over the years, including:
Arctoris has significantly strengthened its executive leadership over the past 12 months with strategic appointments, including a new Chief Operating Officer and a new Chief Commercial Officer, to support its continued growth and expansion in the drug discovery market.
Discover the tools Arctoris uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Arctoris most likely uses standard professional email formats. The common patterns for companies of its profile are [first].[last]@arctoris.com or [first_initial][last]@arctoris.com. Using these formats typically yields a high success rate for reaching intended recipients.
[first].[last]@arctoris.com
Format
martin.bittner@arctoris.com
Example
90%
Success rate
Business Wire • May 7, 2024
Arctoris and Evariste Technologies have initiated a research collaboration to advance Evariste's novel antibiotics program. Arctoris's automated Ulysses® platform will be utilized for Hit-to-Lead and Lead Optimization campaigns, aiming to accelerate the development of new treatments against antimicrobial resistance....more
Arctoris News • February 20, 2024
Arctoris Ltd. and AIGineering announced a research collaboration combining AIGine's AI-driven molecular design capabilities with Arctoris's Ulysses® platform for automated experimentation to accelerate the discovery of small molecule drugs for neurodegenerative diseases....more
Arctoris News • November 28, 2023
Arctoris announced the appointment of Per Matsson, PhD, as its new Chief Commercial Officer. Dr. Matsson brings extensive experience to lead Arctoris's commercial strategy and expand its global business development activities....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Arctoris, are just a search away.